Related Experiment Video
Updated: May 6, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
C3 glomerulopathy: consensus report
Matthew C Pickering1, Vivette D D'Agati, Carla M Nester
1Centre for Complement and Inflammation Research, Imperial College London, London, UK.
Insights
C3 glomerulopathy, a kidney disease marked by C3 protein buildup, needs a clear definition and diagnostic approach. Experts convened to establish consensus on its definition, complement testing, and therapeutic strategies.
Area of Science:
- Nephrology and Renal Pathology
- Complement System Biology
Background:
- C3 glomerulopathy is defined by C3 accumulation in glomeruli with minimal immunoglobulin deposition.
- Recent advancements necessitate a refined understanding and consensus on this pathological entity.
Framework:
- First C3 Glomerulopathy Meeting convened experts in renal pathology, nephrology, and complement biology.
- Objectives included defining C3 glomerulopathy, standardizing complement investigations, and exploring therapeutic avenues.
Implementation:
- The meeting report reflects the expert group's current consensus view.
- Focus on establishing a unified definition and diagnostic criteria.
Implications:
- A consensus framework will guide future research and clinical management of C3 glomerulopathy.
- Standardized investigations and therapeutic exploration are crucial for patient outcomes.
Abstract:
C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Glaucoma: Overview

